Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Hematopoietic Stem Cell Therapy for Young Adults With Severe Sickle Cell Disease

NCT01565616 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01565616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01565616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Hematopoietic Stem Cell Therapy for Young Adults With Severe Sickle Cell Disease
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
June 30, 2016
Enrollment
22 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease